Published in AIDS Weekly, November 18th, 2002
Epimmune's cancer epitopes (antigen fragments) are derived from multiple tumor-associated antigens and contain both native and analog epitope sequences. IDM's technology consists of monocyte derived dendritic cells (dendritophages) loaded in vitro with tumor antigens or epitopes and then reinjected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.